Supporting the delivery of What's the Story

Supporting the delivery of What's the Story

Introduction to the What's the Story study at NUH

The What's the Story study

One of the ways our bodies develop protection against infectious diseases is by developing antibodies, either after an infection or following a vaccination. The Oxford Vaccine Group is carrying out this study to measure the antibody levels against important diseases, including those that are vaccine preventable.

This study involves donation of a blood sample from people aged from birth to-24 years of age to look at their antibody levels against important infectious diseases. It is particularly interested in Group C meningococcus (MenC) and diphtheria and in the novel coronavirus (COVID-19). This would help us understand whether we need to make any changes to the UK vaccine schedule, and tell us about the number of infections with COVID-19 in the UK. 

What happens in this study?

  • We are looking to enrol children and adults aged from birth to 24 years old.
  • There will be a single visit with a blood test.  
  • We will ask if you would be happy to take be approached for additional blood and saliva samples at 2 monthly intervals (this is optional and the maximum number of additional visits is 3)
  • We will ask you some basic information including age, gender, vaccination history.
  • We will arrange to see you in a clinic in a location near to you or in some cases in your home.  
  • Participants seen in clinics will be offered £20 reimbursement in the form of a voucher for taking part in the study. If they are seen at home there will be no reimbursement.
  • Local anaesthetic skin cream would be used for children to reduce any discomfort from blood sampling
  • The whole appointment should take around 45 minutes.

Useful links

What's the Story training materials